These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28100578)

  • 21. Giant conjunctival squamous cell carcinoma. Treatment with surgery following topical interferon alpha-2b.
    Murcia Bello C; Lleó Pérez AV; Navarro Piera JF
    Arch Soc Esp Oftalmol; 2016 Apr; 91(4):188-90. PubMed ID: 26827157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Squamous Cell Neoplasm of the Ocular Surface in a Patient With Psoriasis Treated With Tumor Necrosis Factor-Alpha Inhibitors.
    Lezcano Carduz VP; Mingo Botín D; Durán Poveda SP
    Cornea; 2015 Jul; 34(7):833-4. PubMed ID: 26010941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis].
    Torres Suárez E; Pinheiro R; Schrage N
    Ophthalmologe; 2017 Feb; 114(2):155-158. PubMed ID: 27300720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Conjunctival squamous cell carcinoma: paradoxical response to interferon eyedrops].
    Mata E; Conesa E; Castro M; Martínez L; de Pablo C; González ML
    Arch Soc Esp Oftalmol; 2014 Jul; 89(7):293-6. PubMed ID: 24269461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia.
    Kabra NS; Patil VS; Dhanuka DG
    Indian J Ophthalmol; 2021 Dec; 69(12):3776-3777. PubMed ID: 34827049
    [No Abstract]   [Full Text] [Related]  

  • 28. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.
    Kanaya R; Kase S; Ishijima K; Ishida S
    In Vivo; 2019; 33(6):2211-2215. PubMed ID: 31662558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical interferon alfa-2b for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
    Pérez de Arcelus M; Aranguren M; Andonegui J
    An Sist Sanit Navar; 2012; 35(1):137-41. PubMed ID: 22552136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular surface toxicity associated with topical interferon alpha-2b.
    Aldave AJ; Nguyen A
    Br J Ophthalmol; 2007 Aug; 91(8):1087-8. PubMed ID: 17638822
    [No Abstract]   [Full Text] [Related]  

  • 31. Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).
    Shields CL; Ramasubramanian A; Mellen PL; Shields JA
    Ophthalmology; 2011 Nov; 118(11):2133-2137.e1. PubMed ID: 21762990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interferon alpha 2b for treatment of conjunctival melanoma: a case report].
    Schumacher C; Heinz C; Lommatzsch P; Lommatzsch A; Koch J
    Ophthalmologe; 2013 Aug; 110(8):766-9. PubMed ID: 23319061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical interferon alpha-2b as an adjunctive therapy in recurrent conjunctival papilloma.
    Muralidhar R; Sudan R; Bajaj MS; Sharma V
    Int Ophthalmol; 2009 Feb; 29(1):61-2. PubMed ID: 18000647
    [No Abstract]   [Full Text] [Related]  

  • 34. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
    Nemet AY; Sharma V; Benger R
    Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
    Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC
    Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of conjunctival papillomata with topical interferon Alfa-2b.
    Schechter BA; Rand WJ; Velazquez GE; Williams WD; Starasoler L
    Am J Ophthalmol; 2002 Aug; 134(2):268-70. PubMed ID: 12140037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size.
    Vilaltella M; Huerva V
    Arq Bras Oftalmol; 2021; 85(2):109-114. PubMed ID: 34431893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.
    Parrozzani R; Lazzarini D; Alemany-Rubio E; Urban F; Midena E
    Br J Ophthalmol; 2011 Mar; 95(3):355-9. PubMed ID: 20693564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b.
    Kobayashi A; Yoshita T; Uchiyama K; Shirao Y; Kitagawa K; Fujisawa A; Tseng SC
    Jpn J Ophthalmol; 2002; 46(2):215-7. PubMed ID: 12062230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.